90701065 - MAKE CANCER A BENIGN EXPERIENCE

Information

• Trademark
• 90701065

• Source

• Serial Number

  90701065

• Registration Number

  7287794

• International Classifications

  • 5 - Pharmaceutical and veterinary preparations
  • 44 - Medical services

• Filing Date

  May 10, 2021
  3 years ago

• Registration Date

  January 23, 2024
  a year ago

• Transaction Date

  January 23, 2024
  a year ago

• Status Date

  January 23, 2024
  a year ago

• Published for Opposition Date

  June 14, 2022
  2 years ago

• Location Date

  December 18, 2023
  a year ago

• First Use Anywhere Date

  January 04, 2023
  2 years ago

• First Use In Commerce Date

  January 24, 2023
  2 years ago

• Status Code

  700

• Current Location

  PUBLICATION AND ISSUE SECTION

  Employee Name

  DAWE III, WILLIAM H

• Attorney Docket Number

  413.T002

  Attorney Name

  Ted D. Karr

  Law Office Assigned Location Code

  L80

• Owners

  • Earli Inc.

Case File Statements

• GS0051: Products for the prevention of cancer in humans, namely, pharmaceutical products to express a synthetic biomarker for detecting cancer; Products for the detection of cancer in humans, namely, pharmaceutical products to express a synthetic biomarker for detecting cancer; Products for the localization of cancer in humans, namely, pharmaceutical products to express a synthetic biomarker for localization of cancer; Products for the therapy of cancer in humans, namely, pharmaceutical products to express a treatment agent for treating cancer; Products for the prevention of cancer in animals, namely, pharmaceutical products to express a synthetic biomarker for detecting cancer; Products for the detection of cancer in animals, namely, pharmaceutical products to express a synthetic biomarker for detecting cancer; Products for the therapy of cancer in animals, namely, pharmaceutical products to express a treatment agent for treating cancer
• GS0441: Medical services for the prevention of cancer in humans, namely, medical assay processing provided by medical laboratories and medical analysis services for detecting cancer; Medical services for the detection of cancer in humans, namely, medical assay processing provided by medical laboratories and medical analysis services for detection of cancer; Medical services for the localization of cancer in humans, namely, medical assay processing provided by medical laboratories and medical analysis services for the localization of cancer; Medical services for the therapy of cancer in humans, namely, medical assay processing provided by medical laboratories and medical analysis services for treating cancer; Medical services for the prevention of cancer in animals, namely, medical assay processing provided by medical laboratories and medical analysis services for detecting cancer; Medical services for the detection of cancer in animals, namely, medical assay processing provided by medical laboratories and medical analysis services for detection of cancer; Medical services for the therapy of cancer in animals, namely, medical assay processing provided by medical laboratories and medical analysis services for the treatment of cancer

Case File Event Statements

• 1/23/2024 - a year ago

  39 - NOTICE OF REGISTRATION CONFIRMATION EMAILED Type: NRCC

• 1/23/2024 - a year ago

  38 - REGISTERED-PRINCIPAL REGISTER Type: R.PR

• 12/19/2023 - a year ago

  37 - NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED Type: SUNA

• 12/18/2023 - a year ago

  36 - ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED Type: CNPR

• 12/7/2023 - a year ago

  35 - TEAS/EMAIL CORRESPONDENCE ENTERED Type: TEME

• 12/7/2023 - a year ago

  34 - CORRESPONDENCE RECEIVED IN LAW OFFICE Type: CRFA

• 12/7/2023 - a year ago

  33 - ASSIGNED TO LIE Type: ALIE

• 7/7/2023 - a year ago

  32 - TEAS RESPONSE TO OFFICE ACTION RECEIVED Type: TROA

• 4/10/2023 - a year ago

  31 - NOTIFICATION OF NON-FINAL ACTION E-MAILED Type: GNRN

• 4/10/2023 - a year ago

  30 - NON-FINAL ACTION E-MAILED Type: GNRT

• 4/10/2023 - a year ago

  29 - SU - NON-FINAL ACTION - WRITTEN Type: CNRT

• 2/24/2023 - 2 years ago

  28 - STATEMENT OF USE PROCESSING COMPLETE Type: SUPC

• 2/1/2023 - 2 years ago

  27 - USE AMENDMENT FILED Type: IUAF

• 2/23/2023 - 2 years ago

  26 - CASE ASSIGNED TO INTENT TO USE PARALEGAL Type: AITU

• 2/1/2023 - 2 years ago

  25 - TEAS STATEMENT OF USE RECEIVED Type: EISU

• 8/9/2022 - 2 years ago

  24 - NOA E-MAILED - SOU REQUIRED FROM APPLICANT Type: NOAM

• 6/14/2022 - 2 years ago

  23 - OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED Type: NPUB

• 6/14/2022 - 2 years ago

  22 - PUBLISHED FOR OPPOSITION Type: PUBO

• 5/25/2022 - 2 years ago

  21 - NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED Type: NONP

• 5/10/2022 - 2 years ago

  20 - APPROVED FOR PUB - PRINCIPAL REGISTER Type: CNSA

• 5/10/2022 - 2 years ago

  19 - EXAMINER'S AMENDMENT ENTERED Type: XAEC

• 5/10/2022 - 2 years ago

  18 - NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED Type: GNEN

• 5/10/2022 - 2 years ago

  17 - EXAMINERS AMENDMENT E-MAILED Type: GNEA

• 5/10/2022 - 2 years ago

  16 - EXAMINERS AMENDMENT -WRITTEN Type: CNEA

• 5/7/2022 - 2 years ago

  15 - TEAS/EMAIL CORRESPONDENCE ENTERED Type: TEME

• 5/6/2022 - 2 years ago

  14 - CORRESPONDENCE RECEIVED IN LAW OFFICE Type: CRFA

• 5/6/2022 - 2 years ago

  13 - TEAS RESPONSE TO OFFICE ACTION RECEIVED Type: TROA

• 2/23/2022 - 3 years ago

  12 - NOTIFICATION OF NON-FINAL ACTION E-MAILED Type: GNRN

• 2/23/2022 - 3 years ago

  11 - NON-FINAL ACTION E-MAILED Type: GNRT

• 2/23/2022 - 3 years ago

  10 - NON-FINAL ACTION WRITTEN Type: CNRT

• 1/20/2022 - 3 years ago

  9 - TEAS/EMAIL CORRESPONDENCE ENTERED Type: TEME

• 1/20/2022 - 3 years ago

  8 - CORRESPONDENCE RECEIVED IN LAW OFFICE Type: CRFA

• 1/20/2022 - 3 years ago

  7 - TEAS RESPONSE TO OFFICE ACTION RECEIVED Type: TROA

• 1/13/2022 - 3 years ago

  6 - NOTIFICATION OF NON-FINAL ACTION E-MAILED Type: GNRN

• 1/13/2022 - 3 years ago

  5 - NON-FINAL ACTION E-MAILED Type: GNRT

• 1/13/2022 - 3 years ago

  4 - NON-FINAL ACTION WRITTEN Type: CNRT

• 1/13/2022 - 3 years ago

  3 - ASSIGNED TO EXAMINER Type: DOCK

• 8/10/2021 - 3 years ago

  2 - NEW APPLICATION OFFICE SUPPLIED DATA ENTERED Type: NWOS

• 5/13/2021 - 3 years ago

  1 - NEW APPLICATION ENTERED Type: NWAP